Clari Vest Asset Management LLC Verve Therapeutics, Inc. Transaction History
Clari Vest Asset Management LLC
- $953 Million
- Q2 2024
A detailed history of Clari Vest Asset Management LLC transactions in Verve Therapeutics, Inc. stock. As of the latest transaction made, Clari Vest Asset Management LLC holds 584 shares of VERV stock, worth $2,797. This represents 0.0% of its overall portfolio holdings.
Number of Shares
584
Previous 77,627
99.25%
Holding current value
$2,797
Previous $1.03 Million
99.81%
% of portfolio
0.0%
Previous 0.11%
Shares
3 transactions
Others Institutions Holding VERV
# of Institutions
173Shares Held
74.7MCall Options Held
115KPut Options Held
144K-
Alphabet Inc. Mountain View, CA12.3MShares$59.2 Million3.79% of portfolio
-
Black Rock Inc. New York, NY6.62MShares$31.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.26MShares$25.2 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.53MShares$21.7 Million0.01% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.87MShares$18.5 Million0.01% of portfolio
About Verve Therapeutics, Inc.
- Ticker VERV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,942,300
- Market Cap $287M
- Description
- Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program t...